E. Ohman J or Asset Management AB Sells 619 Shares of Danaher Corporation $DHR

E. Ohman J or Asset Management AB decreased its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,391 shares of the conglomerate’s stock after selling 619 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Danaher were worth $5,411,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. MGO One Seven LLC grew its position in Danaher by 485.7% in the first quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock worth $5,145,000 after acquiring an additional 20,813 shares in the last quarter. Asahi Life Asset Management CO. LTD. bought a new stake in shares of Danaher in the 1st quarter valued at approximately $539,000. UniSuper Management Pty Ltd increased its position in shares of Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock valued at $34,954,000 after purchasing an additional 2,667 shares during the last quarter. Horizon Financial Services LLC lifted its position in Danaher by 20,400.0% in the first quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after buying an additional 8,160 shares during the last quarter. Finally, Texas Capital Bank Wealth Management Services Inc boosted its stake in Danaher by 6.1% during the first quarter. Texas Capital Bank Wealth Management Services Inc now owns 34,763 shares of the conglomerate’s stock worth $7,126,000 after buying an additional 2,009 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $190.07 on Monday. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock’s fifty day moving average price is $201.21 and its 200-day moving average price is $198.78. The firm has a market cap of $136.10 billion, a P/E ratio of 40.44, a P/E/G ratio of 2.65 and a beta of 0.75. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 27.23%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Robert W. Baird increased their target price on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research note on Tuesday, September 2nd. Deutsche Bank Aktiengesellschaft decreased their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Finally, Evercore ISI lowered their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research note on Tuesday, July 8th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $246.35.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.